Loading company details...
Beta
Latest Form 4 (Oct 14, 2026): John C.m. Farquhar (Chief Executive Officer): Sale of 38,900 shares, $1.93M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | John C.m. Farquhar, Chief Executive Officer | Sale | 38,900 | $1.93M |
| Sep 21, 2026 | Campbell Rogers, Chief Medical Officer | Exercise/Conversion | 12,329 | $102.7K |
| Sep 19, 2026 | Vikram Verghese, Chief Financial Officer | Sale | 7,579 | $379.8K |
| Sep 15, 2026 | Vikram Verghese, Chief Financial Officer | Sale | 29,714 | $1.49M |
| Sep 14, 2026 | John C.m. Farquhar, Chief Executive Officer | Sale | 35,010 | $1.63M |
| Sep 10, 2026 | Vikram Verghese, Chief Financial Officer | Sale | 6,640 | $332.2K |
| Sep 4, 2026 | Vikram Verghese, Chief Financial Officer | Sale | 5,876 | $297.3K |
| Aug 25, 2026 | John C.m. Farquhar, Chief Executive Officer | Sale | 27,230 | $1.36M |
| Aug 20, 2026 | John C.m. Farquhar, Chief Executive Officer | Sale | 32,676 | $1.47M |
| Aug 20, 2026 | Campbell Rogers, Chief Medical Officer | Exercise/Conversion | 9,219 | $175.2K |